Paion AG

Paion AG, a specialty pharmaceutical company, develops and commercializes drugs for hospital-based sedation, anesthesia, and critical care services worldwide. The company's lead product is Remimazolam, an ultra-short-acting intravenous benzodiazepine sedative/anesthetic, which is in clinical development for use in procedural sedation, general anesthesia, and intensive care unit sedation. Show More...

  • Website https://www.paion.com
  • Sector Healthcare
  • Industry Drug Manufacturers-Specialty & Generic
  • Last Quote 0.01 EUR
  • Last Updated 30-05-2025
  • External Links Yahoo Finance Morningstar Ratios
  •   2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM
    Earnings Per Share EUR -0.31 -0.44 0.52 -0.09 -0.23 -0.56 -0.38 -0.2 -0.16 -0.11 -0.09
    Dividends EUR
    Payout Ratio % *
    Shares Mil 30.0 31.0 31.0 26.0 41.0 51.0 53.0 60.0 63.0 64.0 62.0
    Book Value Per Share * EUR 0.41 0.25 0.5 0.42 1.28 0.84 0.51 0.47 0.34 0.27 0.23
    Free Cash Flow Per Share * EUR -0.37 -0.19 0.35 -0.15 -0.44 -0.26 -0.33 -0.23 -0.02
    Return on Assets % -29.67 -69.39 78.2 -9.54 -21.53 -51.29 -49.4 -34.62 -35.37 -28.5 -23.7
    Financial Leverage (Average) 2.24 1.82 1.35 1.06 1.22 1.52 1.26 1.17 1.69 1.62
    Return on Equity % -59.18 -237.88 211.92 -15.31 -23.98 -57.48 -66.5 -48.21 -43.17 -39.47 -33.39
    Return on Invested Capital % -55.15 -226.68 211.45 -15.57 -24.12 -57.55 -66.55 -48.27 -43.19 -31.18 -33.39
    Interest Coverage -12.15 -17.28 436.13 -992.37 -75.57
    Current Ratio 3.66 2.71 2.07 3.09 16.06 5.07 2.69 4.41 6.29 2.23
    Quick Ratio 3.4 2.41 2.02 2.85 15.13 4.14 2.31 3.74 5.35 1.93 1.93
    Debt/Equity